Advertisement
AZO vs CVS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZO is a StrongBuy and CVS is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CVS’s FA Score shows that 2 FA rating(s) are green while.
- CVS’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AZO’s TA Score shows that 5 TA indicator(s) are bullish while CVS’s TA Score has 5 bullish TA indicator(s).
- AZO’s TA Score: 5 bullish, 4 bearish.
- CVS’s TA Score: 5 bullish, 5 bearish.
Price Growth
CVS (@Managed Health Care) experienced а -2.72% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was -5.19%. For the same industry, the average monthly price growth was -8.98%, and the average quarterly price growth was -6.52%.
Reported Earning Dates
CVS is expected to report earnings on Jul 30, 2025.
Industries' Descriptions
@Managed Health Care (-5.19% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| AZO | CVS | AZO / CVS | |
| Capitalization | 54.5B | 100B | 55% |
| EBITDA | 4.21B | 18.2B | 23% |
| Gain YTD | 19.502 | 38.646 | 50% |
| P/E Ratio | 22.36 | 12.33 | 181% |
| Revenue | 17.8B | 358B | 5% |
| Total Cash | 304M | 11.5B | 3% |
| Total Debt | 11.8B | 79.4B | 15% |
AZO | CVS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 24 | 65 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 94 Overvalued | 2 Undervalued | |
PROFIT vs RISK RATING 1..100 | 2 | 84 | |
SMR RATING 1..100 | 100 | 78 | |
PRICE GROWTH RATING 1..100 | 17 | 56 | |
P/E GROWTH RATING 1..100 | 20 | 15 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVS's Valuation (2) in the Drugstore Chains industry is significantly better than the same rating for AZO (94) in the Specialty Stores industry. This means that CVS’s stock grew significantly faster than AZO’s over the last 12 months.
AZO's Profit vs Risk Rating (2) in the Specialty Stores industry is significantly better than the same rating for CVS (84) in the Drugstore Chains industry. This means that AZO’s stock grew significantly faster than CVS’s over the last 12 months.
CVS's SMR Rating (78) in the Drugstore Chains industry is in the same range as AZO (100) in the Specialty Stores industry. This means that CVS’s stock grew similarly to AZO’s over the last 12 months.
AZO's Price Growth Rating (17) in the Specialty Stores industry is somewhat better than the same rating for CVS (56) in the Drugstore Chains industry. This means that AZO’s stock grew somewhat faster than CVS’s over the last 12 months.
CVS's P/E Growth Rating (15) in the Drugstore Chains industry is in the same range as AZO (20) in the Specialty Stores industry. This means that CVS’s stock grew similarly to AZO’s over the last 12 months.
| AZO | CVS | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 50% | 3 days ago 63% |
| Stochastic ODDS (%) | 3 days ago 52% | 3 days ago 59% |
| Momentum ODDS (%) | 3 days ago 62% | 3 days ago 52% |
| MACD ODDS (%) | 3 days ago 61% | 3 days ago 55% |
| TrendWeek ODDS (%) | 3 days ago 61% | 3 days ago 58% |
| TrendMonth ODDS (%) | 3 days ago 61% | 3 days ago 54% |
| Advances ODDS (%) | 6 days ago 61% | 6 days ago 62% |
| Declines ODDS (%) | 4 days ago 42% | 4 days ago 59% |
| BollingerBands ODDS (%) | 3 days ago 47% | 3 days ago 64% |
| Aroon ODDS (%) | 3 days ago 52% | 3 days ago 63% |
Advertisement
AZO and
Correlation & Price change
A.I.dvisor indicates that over the last year, AZO has been closely correlated with ORLY. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if AZO jumps, then ORLY could also see price increases.
| Ticker / NAME | Correlation To AZO | 1D Price Change % | ||
|---|---|---|---|---|
| AZO | 100% | -1.19% | ||
| ORLY - AZO | 71% Closely correlated | +0.70% | ||
| GPC - AZO | 49% Loosely correlated | +0.90% | ||
| AAP - AZO | 42% Loosely correlated | +55.45% | ||
| TSCO - AZO | 34% Loosely correlated | -0.68% | ||
| MUSA - AZO | 34% Loosely correlated | +1.04% | ||
More | ||||
CVS and
Correlation & Price change
A.I.dvisor indicates that over the last year, CVS has been loosely correlated with CNC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CVS jumps, then CNC could also see price increases.